Berberine & Kidney Safety: What Specialists Say (2026)

Key Takeaways

Rather than ranking among berberine's side effects, kidney damage appears to be the opposite: preclinical and early clinical evidence suggests berberine may actually protect renal function. A 2025 comprehensive review by Dr. Zhongyu Fan's nephrology team at the First Hospital of Jilin University examined berberine's molecular mechanisms in kidney disease and found it reduces oxidative stress, suppresses fibrosis, and inhibits inflammatory pathways linked to diabetic nephropathy (Fan et al., 2025, Frontiers in Pharmacology). Berberine is primarily metabolized by the liver, not filtered through the kidneys, which is one reason the safety profile for renal function is reassuring at standard doses, though patients with existing kidney conditions should consult a nephrologist.

Why we wrote this. "Is berberine bad for kidneys" gets roughly 5,700 searches per month. Most results either dismiss the concern without evidence or repeat vague warnings. This article reviews a 2025 meta-analysis of 19 studies, a human safety trial, a nephrology mechanistic review, and preclinical studies testing berberine as a kidney protector, so you get the full picture, not just reassurance.

"Is berberine bad for kidneys?" is one of the most searched berberine safety questions, and understandably so. When you take a supplement daily for months, you want to know it is not quietly damaging your organs.

This question matters especially because many berberine users are managing metabolic concerns (blood glucose, cholesterol, insulin resistance) that themselves increase kidney risk.

The good news: no published human study has found berberine to be nephrotoxic at standard doses. The more interesting news: multiple studies suggest berberine may actually be kidney-protective, with potential benefits that surprised even the researchers. This article reviews all the evidence; the reassuring data and the genuine cautions, so you can make an informed decision with your healthcare provider.

Cleveland Clinic's review of berberine notes that in lab studies, berberine may improve renal function by reducing creatinine and blood urea nitrogen levels, and that these beneficial effects may be related to its anti-inflammatory and antioxidant properties (Cleveland Clinic, 2025).

For berberine's broader safety profile: Is Berberine Safe Long Term?. For side effects: Berberine Side Effects.

Is berberine bad for kidneys?

Renal safety data on berberine is reassuring for healthy users: across 27 randomized trials (PMID: 25498346) at 1,000–1,500 mg/day, no renal adverse events were reported, and diabetic nephropathy animal models suggest protective rather than harmful effects. Existing kidney disease changes the risk assessment. Impaired clearance prolongs berberine exposure and requires medical supervision.

A bright-yellow isoquinoline alkaloid extracted from the roots and bark of plants in the Berberidaceae family, including Berberis vulgaris (common barberry), Coptis chinensis (goldthread), Berberis aristata (tree turmeric), and goldenseal. It has been used for thousands of years in Chinese and Ayurvedic medicine, primarily for gastrointestinal infections and diarrhea.

In traditional medicine systems across Asia, berberine-containing herbs have been prescribed for inflammatory and metabolic conditions long before modern pharmacology confirmed their mechanisms. Today, berberine is widely available as a dietary supplement in capsule form.

More recently, research has investigated berberine as a metabolic support compound, with clinical trials examining its effects on blood glucose, lipid metabolism, insulin sensitivity, and body weight.

According to Dr. Mark Hyman, former head of strategy and innovation at the Cleveland Clinic Center for Functional Medicine, berberine activates AMP-activated protein kinase (AMPK), an enzyme that regulates glucose metabolism, lipid metabolism, and cellular energy balance.

This broad metabolic activity is why berberine has attracted research attention, it works through natural metabolic pathways that overlap with those targeted by prescription medications, though through distinct mechanisms (Och et al., 2022, Molecules).

But what does all this have to do with kidneys? A lot because the metabolic conditions berberine addresses (elevated blood glucose, dyslipidemia, elevated blood pressure) are the same conditions that cause chronic kidney damage in the first place. You cannot evaluate kidney safety without understanding what berberine does metabolically.

What does research say about berberine and kidneys?

What did the 2025 meta-analysis of 19 studies show?

No clinical trial has linked berberine to kidney damage in people with normal renal function; the pooled safety record across 3,000+ trial participants (PMID: 25498346) is clean. The legitimate caution applies to pre-existing kidney disease, where slowed berberine clearance raises plasma levels, and to transplant patients, where the cyclosporine interaction is dangerous.

The results were clear: berberine produced a marked reduction in blood urea nitrogen (BUN) with a standard mean difference of −3.31 (95% CI: −4.19 to −2.42) and a significant decrease in serum creatinine with an SMD of −2.67 (95% CI: −3.26 to −2.09). Both BUN and creatinine are waste products filtered by your kidneys, lower levels indicate better kidney function.

Several studies also measured urinary albumin excretion, a sensitive marker of early glomerular damage, and found that berberine reduced proteinuria across multiple renal injury models (Xu et al., 2025, BMC Nephrology).

Important caveat: these 19 studies were conducted in rodent models (rats with elevated blood sugar, cisplatin-treated animals, and other injury models), not human trials. Rat kidney physiology differs from human kidney physiology in drug clearance rates and regenerative capacity, and animal data does not automatically translate to humans.

But the direction of the evidence is consistently protective, not harmful, across multiple kidney injury models: glucose-driven kidney stress, cisplatin-induced acute kidney injury, and infection-associated renal dysfunction.

What did the 2025 human safety trial find?

A 2025 randomized, double-blind, crossover trial tested LipoMicel berberine (an enhanced-bioavailability formulation) at 1,000 mg/day for 30 days in healthy adults.

The study monitored creatinine, glomerular filtration rate (GFR), and electrolytes weekly. Result: no statistically significant changes in any kidney safety marker compared to placebo.

The researchers specifically designed this trial to test kidney safety because the enhanced bioavailability meant higher systemic berberine exposure than standard formulations (PMC12028944).

The logic: if even a higher-bioavailability formulation shows no kidney effect, standard berberine (with less than 1% bioavailability) reaching the renal system is negligible.

Older human trials corroborate this. The Yin 2008 trial (n=116, 13 weeks), Zhang 2010 (n=120, 12 weeks), and Dong 2012 (n=80, 24 weeks) all reported no clinically significant changes in renal function markers versus placebo, though each enrolled participants with normal baseline kidney function, so extrapolating to pre-existing CKD goes beyond what the data supports.

What protective mechanisms did the 2025 nephrology review identify?

The Jilin University nephrology team went deep on this. Their 2025 review in Frontiers in Pharmacology mapped the specific molecular mechanisms by which berberine may protect kidneys across both acute kidney injury (AKI) and chronic kidney stress models.

Key findings include: suppression of NLRP3 inflammasome activation (a central inflammatory driver in kidney injury), reduction of reactive oxygen species (ROS) via Nrf2 pathway activation, inhibition of endoplasmic reticulum stress in renal tubular cells, and blockade of fibrotic signaling through the TGF-β/Smad3 pathway; the process by which functional kidney tissue is replaced by scar tissue.

The review also documented changes in protein expression of apoptosis-related markers (increased Bcl-2, decreased Bax) in treated rat kidney tissue, indicating berberine protected renal cells from programmed cell death (Fan et al., 2025, Frontiers in Pharmacology).

According to the Jilin University researchers, berberine's nephroprotective effects operate partly through AMPK phosphorylation, the same metabolic pathway responsible for berberine's glucose-lowering effects. AMPK activation in kidney cells promotes mitochondrial energy homeostasis via PGC-1α and enhances autophagy (cellular cleanup), both of which are disrupted when blood sugar is chronically elevated.

Can berberine protect the kidneys?

Beyond not harming kidneys, berberine is being actively studied as a kidney protector. In animal and cell models of acute kidney injury, including contrast-induced and cisplatin-induced injury. Berberine lowered serum creatinine and BUN and suppressed NLRP3-inflammasome-driven tubular damage, the same protective signaling mapped in the 2025 Frontiers in Pharmacology nephrology review discussed above (Fan et al., 2025).

Important caveat: this kidney-protection evidence is preclinical, rodent and cell-based, and has not yet been confirmed in human renal-outcome trials. It points to a promising direction, not an established clinical benefit in people. Anyone using berberine specifically hoping to protect already-compromised kidneys should do so only under a nephrologist's guidance.

The honest picture: in models of metabolic kidney stress, berberine looks protective rather than harmful, but the strongest of this evidence remains animal data, and human confirmation is still pending.

How berberine addresses the metabolic drivers of kidney damage

Berberine may protect kidneys indirectly by fixing what damages them. It lowers blood glucose, blood pressure, and LDL cholesterol, the three biggest drivers of chronic kidney disease, and supports weight control. In people with normal renal function, no trial has linked standard-dose berberine to kidney harm.

Most articles about berberine and kidneys focus only on direct nephrotoxicity. But the bigger picture is that berberine may protect kidneys indirectly by improving the metabolic conditions that cause kidney damage in the first place. This may matter more than the direct safety question.

How does berberine's blood-sugar effect protect kidneys?

Chronically elevated blood sugar is the single largest driver of kidney damage globally, blood-sugar-related kidney complications account for roughly 40% of end-stage renal concerns.

Berberine works through multiple metabolic pathways to improve glucose metabolism: it increases glucose uptake into muscle cells via GLUT4 translocation, reduces hepatic glucose production by suppressing gluconeogenesis enzymes, and may improve insulin sensitivity at the receptor level.

A 2022 meta-analysis of 37 randomized controlled trials (3,048 patients) found berberine reduced fasting plasma glucose by 0.82 mmol/L (about 14.8 mg/dL) and HbA1c by 0.63%, with no increase in total adverse events or hypoglycemia risk, and glucose-lowering comparable to metformin in head-to-head studies (Xie & Su et al., 2022, Frontiers in Pharmacology). For details: Berberine Benefits.

According to Dr. Jason Fung, a nephrologist at Scarborough General Hospital and author of The Complete Guide to Fasting, the most effective kidney protection strategy for patients with elevated blood sugar is aggressive glucose control, which is exactly the kind of metabolic support berberine provides through natural AMPK activation.

How does berberine's blood-pressure effect protect kidneys?

Elevated blood pressure is the second leading cause of kidney damage. Sustained arterial pressure damages the delicate glomerular capillaries responsible for filtration.

Evidence indicates berberine may help reduce systolic blood pressure through multiple mechanisms: increasing nitric oxide (NO) bioavailability to promote vascular relaxation, modulating the renin-angiotensin system, and improving endothelial function.

In spontaneously hypertensive rats, the gold-standard animal model for essential elevated blood pressure, berberine attenuated severity and also ameliorated blood-pressure-induced renal injury (Guo et al., 2015, European Journal of Pharmacology).

A separate study in rats with elevated blood sugar found berberine reduced blood pressure while improving vascular nitric oxide production and BKCa channel activity (Wang et al., 2017, Journal of Molecular Endocrinology).

Note: because berberine may lower blood pressure, people who already have low blood pressure or are on blood pressure medications should monitor for drops. For broader metabolic support, berberine pairs well with magnesium glycinate, which also supports healthy blood pressure through a different mechanism.

How does berberine's lipid effect protect kidneys?

Dyslipidemia accelerates kidney damage through lipotoxicity: fatty acid accumulation in renal cells triggers oxidative stress and cellular apoptosis.

Research shows berberine supports healthy LDL levels cholesterol by upregulating hepatic LDL receptor expression through a mechanism distinct from statins (PCSK9 inhibition rather than HMG-CoA reductase inhibition). Research shows berberine may reduce total cholesterol and LDL cholesterol levels by 20–30%, and triglycerides by 25–35%, contributing to improved cardiovascular and metabolic health.

By improving lipid metabolism systemically, berberine may reduce the lipid burden on kidney podocytes, specialized cells that form the filtration barrier. See: Berberine for Cholesterol: What 41 Clinical Trials Show.

How does berberine's weight effect protect kidneys?

Excess body weight independently increases kidney risk through glomerular hyperfiltration and chronic low-grade inflammation.

Clinical trials indicate berberine promotes modest weight reduction (typically 2–5 kg over 12 weeks) through improved lipid metabolism, reduced adipogenesis, and enhanced mitochondrial thermogenesis. While berberine is not a dramatic weight management agent, even modest reductions in body weight reduce glomerular pressure and proteinuria. For the full evidence: Berberine for Weight Loss.

How does berberine affect the gut-kidney axis?

The angle nobody else is covering: berberine may protect kidneys through the gut. The gut-kidney axis is a real and well-documented phenomenon, and berberine acts on it directly. In chronic kidney impairment, reduced renal function leads to accumulation of gut-derived uremic toxins, metabolic waste products generated by intestinal bacteria that healthy kidneys would normally filter out.

The two most harmful are p-cresol sulfate and indoxyl sulfate, both of which accelerate kidney fibrosis and cardiovascular complications.

A landmark 2023 study published in Acta Pharmaceutica Sinica B demonstrated that berberine reduced gut-derived uremic toxins by reshaping the gut microbiome. Specifically, berberine lowered the abundance of Clostridium sensu stricto 1 bacteria and inhibited the tyrosine-to-p-cresol metabolic pathway in the intestinal flora.

The study also found berberine increased butyric acid-producing bacteria and reduced trimethylamine N-oxide (TMAO), another renal toxin linked to cardiovascular problems in people with impaired kidney function (Pan et al., 2023, Acta Pharm. Sin. B).

The 2025 Jilin University nephrology review confirmed this gut-kidney axis mechanism, stating that berberine's ability to reduce gut-derived uremic toxins while reshaping intestinal microbiota composition could become a real management tool for people with chronic kidney impairment.

This matters because most kidney treatments focus only on slowing filtration decline, berberine goes after the toxin source itself, which is the gut bacteria producing the waste your kidneys struggle to clear. For more on berberine's microbiome effects: Berberine and Gut Health.

Why berberine is unlikely to harm kidneys

Berberine's pharmacokinetics explain its renal safety: it has low systemic bioavailability (~5%), is poorly absorbed into blood, and is primarily metabolized by the liver and excreted through bile rather than concentrated in the kidneys. Across 27 randomized trials (PMID: 25498346) at 1,000–1,500 mg/day, no renal adverse events were reported in participants with normal kidney function.

Berberine is metabolized by the liver, not the kidneys. It is processed primarily by CYP2D6 and CYP3A4 liver enzymes, with biliary and fecal excretion as the primary elimination routes. Your renal system is not doing the heavy lifting of processing berberine, unlike substances such as NSAIDs or aminoglycoside antibiotics that are directly nephrotoxic because they concentrate in kidney tissue.

Less than 1% reaches systemic circulation. As we detail in our gut health article, berberine has less than 1% oral bioavailability. The vast majority stays in the gut, working on the microbiome and providing metabolic support through local signaling pathways. The tiny fraction that reaches the bloodstream is metabolized by the liver. The amount that actually reaches kidney tissue is minimal.

Berberine may help reduce the metabolic factors that cause kidney damage. Elevated blood glucose, insulin resistance, high blood pressure, elevated uric acid, and chronic inflammation are the leading causes of kidney problems. Berberine may improve all of these metabolic markers. By supporting healthy glucose levels (see Berberine Benefits), reducing inflammation, and improving insulin sensitivity, berberine may indirectly protect kidneys by addressing the upstream causes of renal dysfunction.

How does berberine compare to truly nephrotoxic substances?

To put berberine's kidney safety in perspective, compare it to substances that actually damage kidneys:

Every known nephrotoxic substance has one thing in common: high kidney exposure, either because it concentrates in renal tissue or because it is eliminated through the kidneys. Berberine has neither characteristic.

How much berberine actually reaches your kidneys?

We can estimate the actual renal exposure from published pharmacokinetic data, a calculation no other berberine article provides.

Start with a 500 mg oral dose. Less than 1% reaches systemic circulation (bioavailability <1%), so roughly 5 mg enters the bloodstream. Of that, the liver metabolizes a large fraction via first-pass CYP2D6/CYP3A4 before it reaches other organs. The remaining berberine distributes across all body tissues. The kidneys represent approximately 0.4% of body weight. Even assuming uniform distribution (which overestimates kidney exposure), the amount of berberine reaching kidney tissue from a single 500 mg dose is in the microgram range, orders of magnitude below any threshold that could cause cellular damage.

For comparison, a single 400 mg ibuprofen dose delivers milligrams of active compound directly to the kidneys via renal clearance.

Which berberine brands are best for kidney-conscious users?

For kidney-conscious users, three quality markers matter most: berberine HCl at ≥97% purity (verified by COA), ISO/IEC 17025 third-party heavy-metal testing (contaminants, not berberine itself, pose the real renal risk), and absence of proprietary blends. Heavy metals like lead and cadmium are nephrotoxic, so contaminant-free sourcing protects kidneys far more than the berberine dose does.

Prices reflect typical retail as of May 2026 and may vary. Potency matters for kidney safety monitoring: if you do not know how much you are actually taking, you cannot track kidney function markers against a known dose.

Who should be cautious

Berberine looks kidney-safe in healthy adults, but some should be careful. Anyone with existing kidney disease, on dialysis, pregnant, or taking drugs cleared by the liver's CYP enzymes should consult a doctor, since berberine can raise blood levels of many medications. The caution here is interactions, not direct toxicity.

Three groups need caution despite berberine's clean renal profile: people with pre-existing chronic kidney disease (impaired clearance prolongs berberine exposure), transplant recipients on cyclosporine (a dangerous CYP3A4 interaction), and anyone with significantly reduced GFR. For these populations, berberine requires physician supervision, not because it damages healthy kidneys, but because compromised kidneys handle it differently.

People with pre-existing kidney concerns (eGFR below 60). There is limited clinical data on berberine specifically in people with advanced kidney impairment. When kidneys are compromised, the metabolic interaction between liver and kidney pathways becomes more complex. If you have diagnosed renal dysfunction at any stage, from early impairment to advanced stages requiring dialysis, consult your nephrologist before starting berberine.

As functional medicine specialist Dr. Layth Tumah notes, patients on dialysis should avoid berberine because their kidneys cannot effectively filter and remove substances from the body (Cleveland Clinic, 2025).

People taking nephrotoxic medications. If you are on medications that stress the kidneys (certain antibiotics, NSAIDs, some chemotherapy agents), adding berberine introduces another variable. One specific concern: berberine can inhibit the CYP3A4 enzyme, which may raise blood levels of certain medications, potentially increasing risk in patients taking compounds like tacrolimus or cyclosporin that are both CYP3A4-metabolized and nephrotoxic at high levels. While berberine itself is not nephrotoxic, combining multiple substances requires medical oversight from your healthcare provider.

People with G6PD deficiency. Individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency or pregnant women may face risks such as jaundice or hemolysis when using berberine. Talk to your doctor before starting.

People on blood sugar medications. Research shows berberine lowers blood glucose through enhanced glucose uptake and reduced hepatic glucose production. Combined with metformin or insulin, this can cause low blood sugar episodes. Severe drops in blood sugar can reduce renal perfusion, this is not berberine being "bad for kidneys," but an indirect risk from over-lowering glucose. See: Can You Take Berberine and Metformin Together?

People on blood-thinning medications. Berberine may inhibit platelet aggregation. For people on anticoagulants (warfarin, heparin) or antiplatelet medications, berberine could theoretically increase the risk of excessive bleeding. While this is not a kidney-specific concern, it is relevant for anyone considering berberine as part of a broader supplement regimen.

Women with hormonal health concerns considering berberine. Berberine use for hormonal balance support is growing due to its effects on insulin resistance and androgen levels. Women in this category with concurrent metabolic concerns may have elevated kidney risk. Monitoring kidney function markers is prudent. See: Berberine for Hormonal Health.

Dr. Dana Ellis Hunnes, a senior clinical dietitian at UCLA Health, emphasizes that while berberine shows promising results, more gold-standard randomized controlled trials are still needed to fully establish its safety profile across all populations (UCLA Health, 2025).

As Medical News Today notes (article medically reviewed by Dr. Darragh O'Carroll, MD for MNT): berberine research is still evolving, and evidence varies by condition, a caution that applies to kidney safety claims in both directions, whether the claim is harm or protection (MedicalNewsToday, 2026).

What are the practical kidney-safety recommendations?

For healthy adults at 500–1,500 mg/day, berberine poses negligible kidney risk based on the 27-trial safety record (PMID: 25498346). Practical recommendations: take berberine HCl with meals, choose third-party-tested products free of heavy metals, stay adequately hydrated, and if you have any kidney condition, obtain a baseline renal panel and physician clearance before starting.

Get baseline labs. Before starting berberine, ask your doctor for a basic metabolic panel that includes creatinine and eGFR. This gives you a reference point. Retest at 3 months. If creatinine and eGFR are unchanged, berberine is not affecting your kidneys.

Stay hydrated. Adequate water intake supports kidney function regardless of what supplements you take. In human studies, berberine is generally well tolerated, with the most common side effects being mild digestive issues such as diarrhea, constipation, nausea, or headache, particularly in the first 1–2 weeks. The GI fluid loss from diarrhea can affect hydration, so adequate water intake matters during the adjustment period. See: Berberine Side Effects.

Standard dosing is well-studied. Most research-backed benefits occur at 500–1,500 mg/day. No published trial at these doses has reported kidney function deterioration. For dosing details: Berberine Dosage Guide.

Choose a product with verified potency. Not all berberine supplements are equal for kidney safety considerations. Our Berberine HCl delivers 1,500 mg per serving with ISO 17025-accredited lab testing, the same dose range used in the safety studies cited in this article. For additional metabolic support, consider pairing with Magnesium Glycinate (supports blood pressure and insulin sensitivity through complementary pathways) or Ashwagandha Plus KSM-66 (supports cortisol regulation, which influences kidney perfusion). For a deeper look at how timing affects results: Best Time to Take Berberine.

Consider the full metabolic picture. If you are using berberine for metabolic support, managing blood glucose, insulin resistance, or body weight, you are already reducing the metabolic risk factors that drive kidney damage. The biggest kidney health benefit of berberine may not be direct nephroprotection but rather the downstream consequence of improved glucose metabolism, lower arterial pressure, and healthier lipid levels.

What critics get wrong

The "berberine is bad for kidneys" concern largely stems from three misunderstandings. Misunderstanding 1: "It lowers blood sugar, so it must stress the kidneys like certain medications." Research shows berberine lowers blood glucose through AMPK activation, enhanced glucose uptake in peripheral tissues, and gut microbiome modulation, mechanisms entirely different from insulin secretagogues.

Misunderstanding 1: "It lowers blood sugar, so it must stress the kidneys like certain medications." Research shows berberine lowers blood glucose through AMPK activation, enhanced glucose uptake in peripheral tissues, and gut microbiome modulation, mechanisms entirely different from insulin secretagogues. There is no mechanism by which berberine concentrates in or damages kidney tissue. Research in rats with elevated blood sugar consistently shows improved, not worsened, kidney histology after berberine treatment, with reduced urinary albumin excretion and preserved glomerular structure.

Misunderstanding 2: "Natural does not mean safe." True in general, aristolochic acid is natural and will destroy your kidneys. But applying this blanket skepticism to berberine specifically ignores the actual evidence. We have decades of safety data from traditional medicine use, plus modern clinical trials specifically measuring kidney function markers, and they consistently show no harm.

The evidence base for berberine kidney safety now includes a meta-analysis, a dedicated human safety trial, and a detailed nephrology review identifying protective signaling pathways and protein expression changes. At some point, repeating "natural does not mean safe" without engaging with the data becomes its own form of misinformation.

Misunderstanding 3: Confusing correlation with causation. Many berberine users have metabolic concerns, a cluster of conditions that itself damages kidneys over time. If a berberine user develops kidney problems, it is far more likely from their underlying metabolic condition (insulin resistance, elevated blood glucose, high blood pressure) than from the berberine. Evidence suggests berberine may actually slow that progression through improved glucose metabolism and reduced oxidative stress.

Still, absence of evidence is not evidence of absence. We do not have 10-year renal outcome studies on berberine. The honest position: short- and medium-term data is reassuring, but very long-term data in people with chronic kidney impairment is still lacking. The gap is not unique to berberine, even many prescription metabolic medications lack long-term renal outcome data, yet modest improvements in metabolic markers are consistently associated with improved kidney function.

What all this means for you

Berberine is not bad for kidneys based on all available evidence. A 2025 meta-analysis of 19 studies found berberine improved kidney function markers including BUN, serum creatinine, and urinary albumin. A human safety trial showed zero kidney changes at enhanced-bioavailability doses. The compound is metabolized by the liver, not the kidneys, and less than 1% reaches systemic circulation. Researchers are even studying berberine as a kidney-protective agent, though so far mainly in preclinical (animal and cell) models rather than human trials.

Beyond direct safety, berberine addresses the metabolic root causes of kidney damage, blood glucose dysregulation, insulin resistance, elevated blood pressure, dyslipidemia, and chronic inflammation, making it one of the few supplements that may provide both metabolic support and potential renal protection through the same mechanisms.

For most healthy adults at standard doses, kidney concerns should not prevent you from using berberine. Get baseline labs, retest at 3 months, and consult a nephrologist if you have existing kidney impairment.

Related Reading:

• Is Berberine Safe Long-Term? What the Research Says
• Berberine Side Effects: What to Expect and How to Manage
• Berberine Benefits: Blood Sugar, Metabolism, and More
• Berberine and Gut Health: How It Reshapes Your Microbiome
• Berberine for Cholesterol: What 41 Clinical Trials Show
• Berberine Dosage Guide: How Much to Take and When
• Best Time to Take Berberine
• Berberine vs. Metformin
• Can You Take Berberine and Metformin Together?
• Berberine for Hormonal Health
• Berberine for Weight Loss
• Berberine and Ashwagandha Together

References

1. Fan Z, et al. (2025). Unveiling the therapeutic potential of berberine in kidney conditions. Frontiers in Pharmacology, 16, 1549462. PubMed
2. Xu W, Fang C, Jiang MJ. (2025). The therapeutic effect of berberine on rodent models of kidney injury: a systematic review and meta-analysis. BMC Nephrology, 26, 315. PubMed
3. LipoMicel Berberine Safety Trial (2025). A 30-day randomized crossover human study on the safety and tolerability of a new micellar berberine formulation. PubMed
4. Pan L, et al. (2023). Berberine ameliorates chronic kidney impairment through inhibiting the production of gut-derived uremic toxins. Acta Pharmaceutica Sinica B, 13(4), 1537–1553. PubMed
5. Liu YF, et al. (2023). Advances of berberine against metabolic-associated kidney concerns. Frontiers in Pharmacology, 14, 1112088. PubMed
6. Qin X, et al. (2020). Berberine protects against glucose-driven kidney stress via promoting PGC-1α-regulated mitochondrial energy homeostasis. British Journal of Pharmacology, 177(16), 3646–3661. PubMed
7. Guo Z, et al. (2015). Blood-pressure-lowering and renoprotective effects of berberine in spontaneously hypertensive rats. European Journal of Pharmacology. PubMed
8. Wang Z, et al. (2017). Berberine reduced blood pressure and improved vasodilation in rats with elevated blood sugar. Journal of Molecular Endocrinology, 59(3). PubMed
9. Zhu L, et al. (2020). Berberine alleviates palmitic acid-induced podocyte apoptosis by reducing ROS-mediated ER stress. Molecular Medicine Reports. PubMed
10. Nawabjan SA, et al. (2025). Renoprotective effect of berberine in cisplatin-induced acute kidney injury: role of Klotho and the AMPK/mTOR/ULK1/Beclin-1 pathway. Food and Chemical Toxicology, 196, 115166. ScienceDirect
11. Blöcher R, et al. (2025). Sex-dependent effects of CYP2D6 on the pharmacokinetics of berberine. Clinical Pharmacology & Therapeutics. PubMed
12. Funk RS, et al. (2017). Variability in potency among commercial preparations of berberine. Journal of Dietary Supplements. PubMed

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not intended as medical advice.

Berberine & Kidney Safety

Metric	Value
Studies reviewed	19 (2025 review)
Kidney injury markers	reduced
Clearance route	liver, not kidneys
Safe dose range (mg)	500–1,500/day
CKD stage 3+	ask nephrologist
Source: 2025 systematic review; hepatic clearance data

Chart: Berberine & Kidney Safety. Data: Studies reviewed: 19 (2025 review); Kidney injury markers: reduced; Clearance route: liver, not kidneys; Safe dose range (mg): 500–1,500/day; CKD stage 3+: ask nephrologist. Source: 2025 systematic review; hepatic clearance data.